Rare Diseases
| Infectious Diseases |
| Skin Diseases |
| Autoimmune Diseases |
| Chronic Diseases |
| Endocrine Diseases |
| Genetic Diseases |
| Nervous System Diseases |
| Blood Diseases |
| Sexually Transmitted Diseases |
Ask An Expert
-Our Community
-Popular Flu
-Today's Poll
Sponsered Ads
Today Quote
" If it weren't for the fact that the TV set and the refrigerator are so far apart, some of us wouldn't get any exercise at all. "Joey Adams
Login Form
Acute Myeloblastic Leukemia (Without Maturation)
DefinitionDefinition of Acute Myeloblastic Leukemia (Without Maturation) Acute myeloblastic leukemia without maturation is a quickly progressing disease in which too many immature white blood cells (not lymphocytes) are found in the blood and bone marrow. SymptomsSymptoms of Acute Myeloblastic Leukemia (Without Maturation) The list of signs and symptoms for Acute myeloblastic leukemia type 2 includes the 50 symptoms listed below:
CausesCauses of Acute Myeloblastic Leukemia (Without Maturation) This subtype is characterized by a translocation of a part of chromosome 8 to chromosome 21, written as t(8;21). On both sides of the splice the DNA coded for different proteins, RUNX1 and ETO, These two sequences are then transcribed and translated into a single large protein, "M2 AML" which allows the cell to divide unchecked, leading to cancer. DiagnosisDiagnosis of Acute Myeloblastic Leukemia (Without Maturation) Home medical testing related to Acute myeloblastic leukemia with maturation:
TreatmentTreatment of Acute Myeloblastic Leukemia (Without Maturation) Systemic chemotherapy includes alkylating agents - usually chlorambucil, cyclophosphamide, vincristine, or fludarabine (singly or in combination) - and steroids (prednisone) when autoimmune hemolytic anemia or thrombocytopenia occurs. An advance in the treatment of CLL has been the emergence of the humanized monoclonal antibodies rituximab and alemtuzumab. Alemtuzumab acts as an antibody against the surface of CLL cells and is used when fludarabine fails. Rituximab, a monoclonal antibody, acts similiarly to alemtuzumab; studies are ongoing. When chronic lymphocytic leukemia causes obstruction or organ impairment or enlargement, local radiation treatment can be used to reduce organ size. Allopurinol can be given to prevent hyperuricemia, a relatively uncommon finding. Prognosis is poor if anemia, thrombocytopenia, neutropenia, bulky lymphadenopathy, and severe lymphocytosis are present. Find Diseases Alphabetically
|
